←
Sethi_Lab294 posts
Sethi_Lab avatar

Sethi_Lab

@LabSethi

Dedicated physicians & scientists determined to improve outcomes in patients with gastrointestinal cancers through basic and translational research @DanaFarber

◷ Joined November 2020▧ 9 Photos and videos
Sethi_Lab avatar
Sethi_Lab@LabSethi·Nov 13

Please share thoughts and feedback on our commentary in @jclinicalinvest . Cancer survivorship genomics is an emerging field with plenty of potential to shape clinical care. How should we interpret mutational signatures in cancer survivors? @MattYurgelun

The genomic afterlife of cancer therapy: doi.org/10.1172/JCI213544 In this Viewpoint, Xiaolu Wang and Nilay S. Sethi @danafarber consider the biological consequences of treatment for long-term cancer survivors. @the_asci

Post attachment
CGA-IGC avatar
⟳ Sethi_Lab retweeted
CGA-IGC@CGAIGC·Oct 26

How are advances in treatment, prevention, and surgical care changing the management of polyposis syndromes? At #CGAIGC26, Dr. Leah Biller, Dr. Jeongyoon Moon, and Dr. Ajay Bansal will explore evolving approaches to polyposis care, from therapy-associated polyposis and functional outcomes following colorectal surgery to the latest evidence in chemoprevention. 🔗 Learn more about our speakers and their presentations: Dr. Leah Biller: bit.ly/4i9BUkH Dr. Jeongyoon Moon: bit.ly/48mF3Yx Dr. Ajay Bansal: bit.ly/4iiaJ6d 📅 November 4 | 10:45 AM – 12:15 PM

Post attachmentPost attachmentPost attachment
Yale Cancer Center avatar
⟳ Sethi_Lab retweeted
Yale Cancer Center@YaleCancer·Oct 20

Congratulations to @MuzumdarLab and @SStevenWang, recipients of an @theNCI #R33 award, which they will use to develop #RAEFISH, an innovative spatial transcriptomics technology. medicine.yale.edu/cancer/new… @SmilowCancer @YaleGenetics

Jun Qi Lab avatar
⟳ Sethi_Lab retweeted
Jun Qi Lab@JunQiLab·Oct 21

It is so exciting to build the understanding of the function differences between EP300 and CBP, which can be applied to target specific therapy development.

This was a major effort between the @Adurbinlab @TheAbraLab @JunQiLab and the Ory labs. We pick up on a long-term interest of our labs: the attractive target, EP300. EP300 is a great cancer target because while many tumor cells require it, they often may not need its paralog CBP

Post attachment
Peggy Hsu MD PhD avatar
⟳ Sethi_Lab retweeted
Peggy Hsu MD PhD@PeggyPHsu·Oct 20

Interested in studying the origins of lung cancer and regulation of development, cell fate, metabolism in human lung progenitors? All in a rigorous, science-loving, supportive environment? I'm looking for postdoctoral fellows, students, technicians! DM me. Please retweet!

Sethi_Lab avatar
Sethi_Lab@LabSethi·Oct 16

Beautiful study by the @Oser_Lab! Crispr screen applied to custom reporter revealed HUWE1 is a stability regulator or ASCL1, lineage TF driving a major subtype of SCLC. Then base editor screens identify functional domains, including an uncharacterized IDR. Elegant and rigorous!

Excited to share another new study from our lab, co-led by Keita Masuzawa and Kevin Dong: “A HUWE1 Regulatory Helix Gates ASCL1 Degradation Through Its C-Terminal Phospho-Degron in Small Cell Lung Cancer.” genesdev.cshlp.org/content/e…

Sethi_Lab avatar
Sethi_Lab@LabSethi·Oct 15

We appreciate the support from @DanaFarber and are grateful to the patients who participated.

A new study in @jclinicalinvest led by @danafarber’s @labsethi sheds light on therapy-associated polyposis, a rare condition that can develop decades after cancer treatment in childhood or young adulthood. For the first time, researchers identified lasting molecular evidence of genetic damage linked to chemotherapy in precancerous colorectal growths. Read more here: bit.ly/4hIrB70

Post attachment
Sethi_Lab avatar
Sethi_Lab@LabSethi·Oct 14

Increased dietary fats leads to more aggressive colorectal cancer via ceramide synthesis and YAP regenerative signaling. A metabolic memory of the exposure persists. science.org/eprint/UAMCP9BAE…